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Timothy J. Steiner1,2*, Gretchen L. Birbeck3,4, Rigmor H. Jensen5, Zaza Katsarava6,7, Lars J. Stovner1,8
and Paolo Martelletti9,10From time to time, there is news that is of particular
consequence to all people affected by headache.
In December 2012, Lancet published the Global
Burden of Disease Study 2010 (GBD2010). We wrote
then [1]: “Few reports are likely to have more profound
meaning for people with headache, or carry greater
promise for a better future, than the seven papers (and
one in particular [2]) that were presented.” So it was: the
essential finding – that migraine was the seventh highest
specific cause of disability worldwide – has been widely
cited in both scientific and informal literature, pointedly
noted by health commentators, trumpeted loudly by lay
organisations and quietly harnessed by those seeking
grants for headache research. It has given legitimacy to
arguments that headache disorders contribute in a big
way to public ill-health and disability [3], and strong
backing to pleas for political recognition of this fact [4].
Now there is more, from the Global Burden of Disease
Study 2013 (GBD2013), and it is of similarly arresting
significance. Published in Lancet earlier this month [5],
its key findings for those whose interests focus on head-
ache are threefold: migraine is the sixth highest cause of
disability worldwide; medication-overuse headache
(MOH) is included in these surveys for the first time
and enters the top twenty causes of disability at 18th;
and adding together just these two puts headache disor-
ders third among the worldwide causes of disability,
measured in years of life lost to disability (YLDs).
Thus in the 23 years of the Global Burden of Disease
project (GBD), from 1990 to 2013, headache has come
from nowhere – wholly ignored, not thought even worth
measuring – into the leading three of the several hun-
dred contributors to the global burden of disease that
GBD counts. The background and a little of the history* Correspondence: t.steiner@imperial.ac.uk
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provided the original work is properly creditedof this extraordinary transition should be told. What we
are reporting here are the outcomes of huge, sustained,
coordinated effort.
GBD itself is a massive, ongoing, iterative enterprise
[6]. It was undertaken initially, in 1990 and 2000, by the
World Health Organization (WHO) but now is led by
the Institute of Health Metrics and Evaluation (IHME)
of the University of Washington, Seattle, WA, USA. Its
stated purpose now is to set out “a comprehensive pic-
ture of what disables and kills people across countries,
time, age, and sex”; towards this, it provides “a tool to
quantify health loss from hundreds of diseases, injuries,
and risk factors, so that health systems can be improved
and disparities can be eliminated” [6]. The data in
GBD2013 came through a consortium of more than
1,000 researchers in over 100 countries, capturing pre-
mature death and disability in 188 countries from more
than 300 diseases [6]. Our objective has been to secure
among these diseases the rightful inclusion of migraine,
tension-type headache (TTH) and MOH: headache dis-
orders that we know cause substantial disability [3].
The Global Campaign against Headache was launched
in 2003 with a clear ultimate purpose: to reduce the bur-
den of headache worldwide [7]. At that time, 12 years
ago, it was not at all clear what this burden was, either
in scope or scale. As a result of some lobbying during
discussions with WHO in the years prior to the Cam-
paign’s launch, GBD2000 included migraine [8]. No other
headache disorders made it, but this was nevertheless a
major advance for those concerned about headache, not
just because GBD1990 had ignored headache totally but
far, far more because migraine was found – on the evi-
dence submitted – to be in the leading 20 causes (19th) of
disability worldwide [8]. This “discovery” propelled head-
ache disorders into WHO’s priorities [3, 4].
For the Campaign this was merely a call to arms, be-
cause also clear at that time was that the evidence sub-
mitted to GBD2000 was seriously deficient. Of course it
related only to migraine, which was neither the mostticle distributed under the terms of the Creative Commons Attribution License
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but this was not the issue. Migraine was certainly the
best studied of the headache disorders, from all aspects
including epidemiologically, and the epidemiological evi-
dence then available from all studies of acceptable qual-
ity had been thoroughly collated (it was later published
as a review [9]). The problem was that it focused
strongly on North and South America and Western
Europe, with a small Far-East cluster of studies in Japan,
Taiwan and the Korean peninsula; left unrepresented
were most of the Western Pacific Region (including
mainland China), all of South East Asia (including
India), all of the Eastern Mediterranean Region, most of
Africa and all of Eastern Europe (including Russia). The
people unrepresented in these territories were more than
half the world’s population.
Not long after the Global Campaign launched, data
collection began for GBD2010 (which was initially to
be GBD2005). Filling the largest of the data gaps was
therefore the first priority of Lifting The Burden (LTB),
the UK-registered charity conducting the Campaign [10,
11]. LTB had two objectives for GBD2010: to secure in-
clusion of the other headache disorders of public-health
importance – TTH and MOH – and to show, as we
then believed, that headache disorders collectively were
among the top ten causes of disability worldwide. It be-
came something of a race against time, firstly to develop
the methodology for population-based door-to-door
studies with a validated diagnostic questionnaire based
on ICHD-II [12] and then to implement it in the big
countries: China, India and Russia, home to 2.5 billion
people. These things were done, and, with much better
information, GBD2010 reported migraine more realistic-
ally as the seventh highest specific cause of disability
measured in YLDs [1, 2]. This of course achieved LTB’s
first objective. As for the second, TTH was included in
the survey, but with a very low disability weight (DW)
allocated to it. GBD2010 reported TTH as the second
most prevalent disorder in the world (after dental car-
ies), and migraine third [2], but despite this TTH added
rather little compared with migraine to the global dis-
ability burden. What about MOH? This was initially in-
cluded but not in the end reported because, it was
argued – correctly, we believe, that prevalence data were
not good enough to support regional estimates of burden
attributable to this disorder. The particular difficulties
of estimating MOH prevalence were recently discussed
[13, 14]. Nonetheless, a DW was allocated to MOH, which
was of crucial importance when it came to GBD2013.
In the interim, between GBD2010 and GBD2013, LTB
had supported further Global Campaign studies in Nepal
in South East Asia, in Saudi Arabia and Pakistan in Eastern
Mediterranean and in Zambia and Ethiopia in Africa –
huge knowledge gaps – while collaborating with GBD incollating data published by other workers. The particular
importance of the LTB studies lay in their use of similar
methodology [15], the inclusion of MOH in their enquiries
and the purposive selection of countries for survey.
GBD2013 was therefore considerably better informed than
GBD2010, not only with more comprehensive regional
data but also, and in particular, with greatly enhanced data
on MOH (and a DW available from GBD2010 for YLD
estimates).
LTB has prioritised this work on data gathering and our
collaboration with GBD above all else. It has involved
multiple complex studies in all world regions, and taken
most of our resources, but as a policy we believe it has
been strategically correct. If the ultimate purpose of the
Campaign is to reduce the burden of headache worldwide,
it must first be known what this burden is – the Cam-
paign’s first objective [7]. At the same time, working with
GBD does much to achieve the Campaign’s second object-
ive, which is creation of awareness of this burden. Indeed
this work of data gathering continues, with studies on-
going or planned in countries in Central and South Amer-
ica, North and West Africa and South East Asia. We have
not forgotten children and adolescents, for which studies
can be school-based [16]. All of these will not only benefit
future iterations of GBD but also, just as importantly,
serve as needs-assessment studies informing health policy
locally, in the countries and regions where the data are
gathered.
To end, it would be easy to claim the findings of
GBD2013 as a triumphal conclusion of prolonged hard
effort, since on a technical level they are, but that would
overlook their tragic meaning. As we reported earlier
[1], GBD measures disease burden as it is – alleviated by
whatever treatments are made available. Headache disor-
ders, we said at the time of GBD2010, were among the
top ten causes of disability because they were common
and disabling, but we asked: “For what conceivable rea-
son do headache disorders remain among these igno-
minious top ten when they are largely treatable?” [1].
Now we must ask the chastening question: “Why are
they among the top three?”
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